Diaceutics (LON:DXRX) Sets New 52-Week High – What’s Next?

Diaceutics PLC (LON:DXRX) hit a new 52-week high during trading on Wednesday . The stock traded as high as GBX 151 ($1.84) and last traded at GBX 145.50 ($1.78), with a volume of 416157 shares. The stock had previously closed at GBX 137.50 ($1.68).

Wall Street Analyst Weigh In

A number of research analysts have recently commented on DXRX shares. Canaccord Genuity Group reissued a “buy” rating and issued a GBX 160 ($1.95) target price on shares of Diaceutics in a report on Tuesday, December 17th. Canaccord Genuity Group reissued a “buy” rating and issued a GBX 160 ($1.95) price objective on shares of Diaceutics in a research note on Tuesday, December 17th.

Diaceutics Price Performance

The stock has a market cap of £122.90 million, a price-to-earnings ratio of -4,850.00 and a beta of 0.58. The firm’s fifty day moving average price is GBX 122.89 and its two-hundred day moving average price is GBX 126.77. The company has a debt-to-equity ratio of 2.93, a current ratio of 4.85 and a quick ratio of 9.92.

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.